NCT06964659Not yet recruitingEarly phase 1
Chronic Intervention With Sulforaphane-Smart® in Overweight and Obese Adults
Sulforaphane-Smart® on Lipid and Glucose Metabolism, Inflammation, Adiposity and Microbiome of Overweight Adults "SANO"
Source: ClinicalTrials.gov · Last updated 9 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The Sulforaphane-Smart® formula is a pill, patented by the company INGREDALIA, prepared with broccoli by-products which have been concentrated and enriched in glucosinolates/isothiocyanates (GLS/ITCs). The goal of this intervention study is to evaluate if the chronic consumption of GSL/ITC (Sulforaphane Smart® formula) could modulate the biomarkers related to chronic inflammation, oxidative stress and gut microbiota in overweight and obese volunteers. In order to reach this goal, the volunteers will take daily the Sulforaphane Smart® formula during 12 weeks (total of 84 days). Anthropometric measurements will be taken and biological samples of blood, urine and feces will be collected at the beginning of the intervention (initial time), after six weeks of the intervention (Time 6 weeks) and at the end of the intervention (Time 12 weeks).
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 7 Mar 2025
- Start date
- Jul 2025
- Primary completion date
- Sept 2026
- Lead sponsor
- Mª Jesús Periago
- Diseases
- Obesity
- NCT number
- NCT06964659
What you commit to
- Study type: Interventional · Early phase 1
- Planned participants: 40
- From Jul 2025 to the primary completion date, Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having antibiotics during the previous three months
Other illness
- Digestive or intestinal diseases
Age
- Age different from that required
Other
- BMI: low and normal weight
- Having pharmacological treatments
- Following restrictive diets (vegetarian/vegan diet) or nutritional supplement
- Smoker
Who the study is looking for
- BMI: overweight and obese (BMI 25-34,9 Kg/m2)
- No digestive or intestinal diseases
- Age between 20 and 45 years old
- Not having antibiotics during the previous three months
- Not having pharmacological treatment
- Not being smokers
- Not following restrictive diets (vegetarian/vegan diet) or nutritional supplement
Age in the registry: 20 years to 45 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Edificio Pleyades-Vitalys 5ª y 6ª planta, Campus Universitario, Espinardo Coordinator of this site? Confirm its status | Murcia | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.